Showing 1 - 20 results of 34 for search '"Human Vaccines & Immunotherapeutics"', query time: 0.04s Refine Results
  1. 1
    Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention

    Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention by Wenhui Hu, Han Feng, Ying Liu, Xiaoshuang Xu, Ping Zhou, Zhonghua Sun, Xinyu Tao, Jiahui Yang, Jun Wu, Chen Qu, Zhengxia Liu

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents

    Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents by Amparo L. Figueroa, Kashif Ali, Gary Berman, Wenqin Xu, Weiping Deng, Bethany Girard, Anne Yeakey, Karen Slobod, Jacqueline Miller, Rituparna Das, Frances Priddy

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)

    The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV) by Adewunmi Akingbola, Abiodun Adegbesan, Olajumoke Adewole, Kolade Adegoke, Akpevwe Emmanuella Benson, Paul Ayomide Jombo, Sandra Uchechukwu Eboson, Victor Oluwasola, Ademola Aiyenuro

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial

    Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial by Jelena Tica, Veronica V. Rezelj, Benoit Baron, Vitalija van Paassen, Javier Zaidman, Lee Fairlie, Gert Scheper, Mathieu Le Gars, Frank Struyf, Macaya Douoguih, Javier Ruiz-Guiñazú

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India

    Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India by Nitin Shah, M.M.A. Faridi, Sheila Bhave, Apurba Ghosh, S. Balasubramanian, Vidya Arankalle, Raju Shah, Amar Jeet Chitkara, Arun Wadhwa, Jaydeep Chaudhry, Ramesh Srinivasan, M. Surendranath, Amita Sapru, Monjori Mitra

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies

    Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies by Anna R. Giuliano, Joel M. Palefsky, Stephen E. Goldstone, Jacob Bornstein, Ilse De Coster, Ana María Guevara, Ole Mogensen, Andrea Schilling, Pierre Van Damme, Corinne Vandermeulen, Misoo C. Ellison, Susan Kaplan, Jianxin Lin, Rachael Bonawitz, Alain Luxembourg

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Disease burden of influenza in Spain: A five-season study (2015–2020)

    Disease burden of influenza in Spain: A five-season study (2015–2020) by Iván Sanz-Muñoz, Irene Arroyo-Hernantes, Alejandro Martín-Toribio, Marina Toquero-Asensio, Javier Sánchez-Martínez, Carla Rodríguez-Crespo, Silvia Rojo-Rello, Marta Domínguez-Gil, Marta Hernández-Pérez, Eduardo Tamayo, Ruth Gil-Prieto, Ángel Gil-de-Miguel, José M Eiros

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial

    Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial by Siyue Jia, Chengwei Shao, Xin Cheng, Hongxing Pan, Zhijian Wang, Yu Xia, Jianfang Xu, Xuefen Huai, Danjing Leng, Jiarong Wang, Gan Zhao, Bin Wang, Jingxin Li, Fengcai Zhu

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Unreliable information and fear: Barriers to vaccination among IBD patients in China

    Unreliable information and fear: Barriers to vaccination among IBD patients in China by Jingwen Liu, Zelin Yan, Wen Hu, Shuyan Li, Yan Chen

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Administration of non-national immunization program vaccines for children under six in a rural county, Henan Province: Did costs matter?

    Administration of non-national immunization program vaccines for children under six in a rural county, Henan Province: Did costs matter? by Miaomiao Yin, Yuan Cao, Xiaolin Xu, Hanzhi Peng, Yu Wang, Qian Long

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines

    Targeting murine metastatic cancers with cholera toxin A1-adjuvanted peptide vaccines by Sanchari Paul, Mustafa Kaya, Olivia Johnsson, Hanna Grauers Wiktorin, Andreas Törnell, Mohammad Arabpour, Kristoffer Hellstrand, Anna Martner

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Adverse events following immunization surveillance on two types of enterovirus 71 vaccines: A real-world comparative study in China

    Adverse events following immunization surveillance on two types of enterovirus 71 vaccines: A real-world comparative study in China by Yiqing Zhu, Yihan Wang, Jinghui Wang, Yafei Wang, Li Sun, Shiheng Cui, Jing Li, Yu Guo

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Beijing of China

    Analysis of a case of pilomatricoma in an adolescent after receiving recombinant hepatitis B vaccine (CHO cell) in Beijing of China by Li Li, Jingyi Xu, Dongkun Zhang, Jianlin Cai, Zhen Li, Xiaohui Zhang, Shuping Li

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children

    Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children by Stephanie A. Davey, James Elander, Amelia Woodward, Michael G. Head, Daniel Gaffiero

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Strategies for introducing and implementing vaccines for adults into national immunization programs in Europe: Good practices and key insights of the adult immunization board meeting

    Strategies for introducing and implementing vaccines for adults into national immunization programs in Europe: Good practices and key insights of the adult immunization board meeti... by Sara Boccalini, Angela Bechini, Marco Del Riccio, Birgit Weinberger, Jacek Wysocki, Domenico Martinelli, Ole Wichmann, Tiina Likki, Greet Hendrickx, Pierre Van Damme, Chloé Wyndham-Thomas, Paolo Bonanni, Jade Pattyn

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Pembrolizumab- induced subacute cutaneous lupus erythematosus in a patient with oropharyngeal squamous cell carcinoma: A case report and literature review

    Pembrolizumab- induced subacute cutaneous lupus erythematosus in a patient with oropharyngeal squamous cell carcinoma: A case report and literature review by Beata Mayer, Pavel Babál, Lucia Krivošíková

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Research trends of neoadjuvant therapy for breast cancer: A bibliometric analysis

    Research trends of neoadjuvant therapy for breast cancer: A bibliometric analysis by Laiping Xie, Yuhang Wang, Andi Wan, Lin Huang, Qing Wang, Wanyan Tang, Xiaowei Qi, Xiaofei Hu

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Surveillance on the coverage of herpes zoster vaccine and post-marketing adverse events in Jiangsu province, China

    Surveillance on the coverage of herpes zoster vaccine and post-marketing adverse events in Jiangsu province, China by Xiang Sun, Lei Zhang, Tingting Zhang, Jinning Sun, Yan Xu, Li Liu, Yuan Bao Liu, Ran Hu, YaLi Fu, Zhiguo Wang, Hui Sun

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Acceptance and attitudes towards COVID-19 vaccination during pregnancy in Canada

    Acceptance and attitudes towards COVID-19 vaccination during pregnancy in Canada by Suraya Bondy, Elisabeth McClymont, Gal Av-Gay, Arianne Albert, Janice Andrade, Sandra Blitz, Ianna Folkes, Lucia Forward, Erin Fraser, Sela Grays, Jon Barrett, Julie Bettinger, Tali Bogler, Isabelle Boucoiran, Eliana Castillo, Rohan D’Souza, Darine El-Chaâr, Shaza Fadel, Verena Kuret, Gina S. Ogilvie, Vanessa Poliquin, Manish Sadarangani, Heather Scott, John W. Snelgrove, Modupe Tunde-Byass, Deborah Money

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studies

    PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse... by John M. Hickey, Nitya Sharma, Max Fairlamb, Jennifer Doering, Yetunde Adewunmi, Katherine Prieto, Giulia Costa, Benjamin Wizel, Elena A. Levashina, Nicholas J. Mantis, Jean-Philippe Julien, Sangeeta B. Joshi, David B. Volkin

    Published 2025-12-01
    “…Human Vaccines & Immunotherapeutics…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: